tirzepatide for cardiovascular disease event risk assessment: a pre-specified meta-analysis Tirzepatide demonstrates cardiovascular protection in

Discussion Previously, we showed that ARID1A-deficient cancers are vulnerable to GSH inhibition through attenuated transcription of SLC7A11 15,16

Learn more about the publication here: #BBraunIndia #SharingExpertise #Hemodiafiltration #ChronicKidneyDisease #KidneyReplacementTherapy To view or add a comment, sign in The publication of An Indian Consensus on the Use of Online Hemodiafiltration (HDF) in Patients with Chronic Kidney Disease in the peer-reviewed journal Blood Purification represents the culmination of a focused journey that began in February 2025, bringing together leading nephrologists through extensive collaboration, scientific dialogue, and consensus-building

In the current analysis, all five individual risk factors of metabolic syndrome were improved after tirzepatide treatment, particularly the hyperglycemia component and to a lesser extent HDL cholesterol

Small, frequent sips work better than trying to drink large amounts at once